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1  | INTRODUC TION
Glucose, the main energy substrate of the brain (see McKenna, 
Dienel, Sonnewald, Waagepetersen, & Schousboe, 2012), is con‐
verted to pyruvate in the glycolytic pathway, which can either be re‐
duced to lactate by lactate dehydrogenase or oxidized to acetyl‐CoA 
by pyruvate dehydrogenase. In the latter case, further oxidation to 
CO2 takes place in the tricarboxylic acid (TCA) cycle. The reactions 
in the TCA cycle represent the key processes in the generation of 
chemical energy in the form of ATP since the reduced co‐enzymes 
generated by the oxidative processes of the cycle are utilized by 
the respiratory chain to convert ADP to ATP (for references, see 
McKenna et al., 2012). In addition to its role in energy production, 
the TCA cycle can be considered a biosynthetic pathway since some 
of its intermediary constituents such as oxaloacetate and α‐ketoglu‐
tarate can be converted primarily to aspartate and glutamate from 
which glutamine and GABA can be produced. Removal of these TCA 
cycle keto‐acids represents a drain of the TCA cycle constituents 
and hence, they must be replaced thereby allowing the continued 
function of this essential pathway. The process needed for this re‐
placement is termed anaplerosis and this process requiring the en‐
zyme pyruvate carboxylase (PC) constitutes the topic of this review. 
Labeled glucose has been used extensively to analyze the synthesis 
of these compounds representing the anaplerotic process.
2  | DISCUSSION
2.1 | Early studies of glutamate metabolism and 
synthesis using radiolabeled glucose
Studies by Berl, Nicklas, and Clarke (1968) and Berl and Clarke 
(1969) using radiolabeled glucose and other substrates for brain 
metabolism had pointed out that glutamate metabolism must be 
complex possibly reflecting the cellular composition of the brain 
by neurons and astrocytes likely exchanging metabolites. Thus, 
when [14C]glucose was the substrate, the radioactive labeling of 
glutamate and glutamine followed the classical precursor–product 
relationship in which the product (glutamine) has a lower specific 
radioactivity than that of its precursor (glutamate). On the con‐
trary, when [14C]acetate was used as the substrate, the opposite 
relationship was found, i.e., the specific radioactivity of glutamine 
was higher than that of glutamate. This can only be explained 
assuming at least two metabolic pools of glutamate having dif‐
ferent turnover rates concerning the conversion to glutamine as 
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Abstract
The first two publications dealing with the question of the cellular localization of the 
enzyme pyruvate carboxylase (PC) which in the brain represents the most important 
metabolic pathway to allow anaplerosis of TCA cycle constituents were published in 
1983 and 1985. Hence, 2018 marks the 35th anniversary of the notion based on the 
results of the publications provided above that PC‐catalyzed anaplerosis in the brain 
is an astrocytic process. This review will provide the background for investigating this 
enzymatic pathway as well as a discussion of cataplerosis, the degradation of prod‐
ucts from anaplerosis, and the current status of the functional significance of pyru‐
vate carboxylation in brain metabolism.
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pointed out by Garfinkel (1966), Berl et al. (1968) and van den 
Berg and Garfinkel (1971). This led to the notion that the cellu‐
lar composition of the brain, i.e., neurons and glial cells, would 
allow an exchange between the cellular compartments of the 
two amino acids in question (Balazs, Machiyama, & Patel, 1973). 
However, it was not until the discovery that the glutamine syn‐
thesizing enzyme, glutamine synthetase (GS), is astrocyte spe‐
cific (Martinez‐Hernandez, Bell, & Norenberg, 1977) that the 
glutamate–glutamine cycle involving astrocytes and glutamater‐
gic neurons could be proposed (see Cotman, Foster, & Lanthorn, 
1981).
2.2 | Misconceptions regarding net synthesis based 
on labeling
Another important finding regarding the radiolabeling of gluta‐
mate from [14C]glucose was that the labeling in glutamate was ex‐
tremely rapid (Berl et al., 1968). Since the use of radiolabeling with 
14C does not easily allow the determination of the specific car‐
bons being labeled in the metabolites generated from, e.g., [14C]
glucose, a rapid labeling may be interpreted as a net synthesis. 
Since glutamate was considered a neurotransmitter (Curtis, Phillis, 
& Watkins, 1959), the general assumption based on its rapid labe‐
ling from[14C]glucose was that neurons could perform a net syn‐
thesis of glutamate from glucose (see Shank & Campbell, 1983). 
However, it is important to distinguish between, on the one hand, 
cycling of label from metabolites, which does not change the con‐
centration and, on the other hand, net synthesis, which may in‐
crease or maintain the amount of metabolites, possibly as a result 
of depletion of a particular metabolite. In the former case, carbon 
skeletons are preserved to a certain extent, and in the latter they 
are lost from the system, which requires a de novo synthesis to 
maintain the original content.
2.3 | Need for CO2 fixation to allow net 
synthesis of glutamate
The carbon skeleton of glutamate originates metabolically from α‐
ketoglutarate, a key intermediary of the TCA cycle and hence, a net 
synthesis of glutamate will lead to a depletion of TCA cycle constitu‐
ents (see McKenna et al., 2016). In order for the cycle to maintain its 
operation, there must be a mechanism by which a de novo synthe‐
sis of TCA cycle constituents can be performed, i.e., an anaplerotic 
metabolic pathway. Three enzymes are capable of catalyzing such a 
pathway, namely malic enzyme (ME), phosphoenolpyruvate carbox‐
ykinase (PEPCK), and pyruvate carboxylase (PC). In the brain, the 
reaction catalyzed by PC is the quantitatively most prominent (Patel, 
1974). The availability of the substrate carbon dioxide/bicarbonate 
as well as the obligatory activator, acetyl‐CoA, represents the main 
regulatory entities for the enzyme. It was therefore of interest to 
establish the cellular localization of this enzyme and almost at the 
same time two research groups set out to investigate this, using dif‐
ferent approaches (Shank, Bennett, Freytag, & Campbell, 1985; Yu, 
Drejer, Hertz, & Schousboe, 1983). Figure 1 shows a schematic pres‐
entation of the processes involved in anaplerosis.
2.4 | Studies aimed at determining the 
cellular localization of CO2 fixation, the role of 
pyruvate carboxylation, and the role of neurons 
versus astrocytes
The study by Yu et al. (1983) utilized the availability of highly puri‐
fied and functionally intact primary cultures of astrocytes and glu‐
tamatergic as well as GABAergic neurons to measure the enzymatic 
activity of PC in the cells and as a control in homogenates from 
brains of new‐born and adult animals. The PC activity was found to 
be higher in the cultured astrocytes than in homogenates from adult 
brain and at the same time the PC activity was below the detection 
limit in the cultured neurons. On the basis of this, it was concluded 
that PC must be an astrocyte‐specific enzyme not expressed in 
neurons. Shortly after, Shank et al. (1985) using a PC‐specific anti‐
body and immunocytochemical staining of brain slices also showed 
astrocyte‐specific expression of the enzyme, a finding confirmed 
10 years later by Cesar and Hamprecht (1995) using monoclonal an‐
tibodies against rat and mouse PC. Another report summarizing the 
use of 13C‐labeled precursors also concluded that the pyruvate car‐
boxylation process mainly if not exclusively takes place in astrocytes 
Significance
The demonstration of a preferential if not exclusive non‐
neuronal, glial expression of the enzyme pyruvate carboxy‐
lase has facilitated the conclusion that only glial cells are 
capable of performing a net synthesis of the precursor for 
neuronal synthesis of the neurotransmitter amino acids: 
glutamate and GABA. Hence, a glial–neuronal exchange of 
metabolites is mandatory for the maintenance of the neuro‐
transmission processes mediated by these two amino acids, 
processes that govern an overwhelming fraction of neuro‐
transmission. The review provides the background for un‐
derstanding the importance of this process. An example of 
the importance of this anaplerotic process is its involvement 
in the amelioration of the effects of hepatic encephalopa‐
thy, allowing fixation of excess ammonia as the amide group 
in glutamine synthesized in astrocytes.
F I G U R E  1   Schematic presentation of pyruvate carboxylation. 
Abbreviation: TCA, tricarboxylic acid
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(Sonnewald & Rae, 2010). Altogether, this provides solid evidence 
that anaplerosis of the TCA cycle can only take place in the astro‐
cytes and not in neurons. It should, however, be noted that pyru‐
vate carboxylation was later found to take place in oligodendrocytes 
(Amaral, Hadera, Tavares, Kotter, & Sonnewald, 2016).
2.5 | Discussions of the role of the glutamate/
glutamine cycle regarding its quantitative 
stoichiometry
The above findings concern the cellular localization of the two 
enzymes, PC and GS, the combined action of which allows a net 
synthesis of glutamine to be performed, being a part of the glu‐
tamate–glutamine cycling between neurons and astrocytes. This 
additionally explains the compartmentation of the glutamate pool 
indicated by the metabolic studies mentioned above. The cycle was 
originally conceived as a stoichiometric (1:1) exchange of glutamate 
release from neurons as a neurotransmitter from glutamatergic 
neurons with glutamine produced in astrocytes after the uptake 
of the transmitter glutamate (Cotman et al., 1981). In this context, 
it should be mentioned that it had been shown that astrocytes ex‐
pressed a highly efficient high affinity uptake system for glutamate 
(Hertz, Schousboe, Boechler, Mukerji, & Fedoroff, 1978; Schousboe, 
Svenneby, & Hertz, 1977), a notion confirmed by the advent of clon‐
ing of the transporter and production of specific antibodies raised 
against the major types of these transporters (Danbolt, 2001).
If indeed the glutamate–glutamine cycle were to operate in a 
strict 1:1 stoichiometric fashion, glutamate taken up into astrocytes 
from the synaptic cleft would need to be quantitatively converted to 
glutamine in the GS‐catalyzed reaction, amidating glutamate at the 
cost of ATP. Several studies have, however, provided unequivocal 
evidence that some of the glutamate taken up into astrocytes un‐
dergoes oxidative metabolism (for references, see McKenna, 2013; 
McKenna et al., 2016; Olsen & Sonnewald, 2015; Parpura et al., 
2017; Schousboe, Scafidi, Bak, Waagepetersen, & McKenna, 2014; 
Sonnewald, 2014). Hence, the glutamate–glutamine cycle does not 
operate in a 1:1 stoichiometric fashion and therefore pyruvate car‐
boxylation is an important reaction providing the means to maintain 
glutamate levels constant even when glutamate serves the role as an 
energy substrate.
2.6 | Activity of PC relative to the rate of 
glutamate cycling
If indeed, as originally suggested, the glutamate–glutamine cycle 
did operate in a stoichiometric fashion, the rate of the PC‐cata‐
lyzed fixation of CO2 should be negligible compared to that of the 
cycling rate. A number of studies have been performed aimed at 
elucidating this question (for references, see Table 1 and Öz, Okar, 
& Henry, 2012). According to these studies, the rate of the PC re‐
action varies between 6% and 50% of the rate of the cycle, i.e., a 
rather high degree of variation. However, it may be safe to conclude 
that the rate of pyruvate carboxylation is not negligible strongly 
underlining the fact that numerous studies as pointed out above 
have shown a high rate of glutamate oxidation. In a study using 
both 13C‐labeled glucose and 14C‐labeled bicarbonate instead of 
only [13C]glucose to estimate the two rates (Öz et al., 2004), it was 
found that the rate of the PC reaction was around 30% of that of 
the cycle, i.e., close to the average of the abovementioned rates 
determined using [13C]glucose as the only labeled substrate.
2.7 | Net synthesis and release of citrate 
from astrocytes
As discussed above, astrocytes are obligatory for the de novo syn‐
thesis of glutamine. Interestingly, it was shown using cultures of 
neurons and astrocytes and [13C]glucose to label metabolites and 
subsequently NMR spectroscopy for analysis of the labeling patterns 
that cultured astrocytes but not cultured neurons exhibited a con‐
siderable release of [13C]citrate to the incubation media (Sonnewald 
et al., 1991). Labeling of citrate was also observed in a similar 13C la‐
beling study using guinea pig brain slices by Badar‐Goffer, Bachelard, 
and Morris (1990), but these authors could not show a release of 
citrate. Citrate release from neurons and astrocytes was subse‐
quently determined in preparations of glutamatergic neurons (cere‐
bellar granule cells) as well as in cerebellar astrocytes (Westergaard, 
Waagepetersen, Belhage, & Schousboe, 2017; Westergaard et al., 
1994) and the release rate was almost 20 times higher in astrocytes 
compared to neurons. Interestingly, the release rate was similar to the 
activity of PC and the rate of CO2 fixation in astrocytes (Kaufmann & 
Driscoll, 1992; Yu et al., 1983). Altogether, these findings underline 
PDHn PC %PC PDHg %PDHg CMRglc
Rata 1–1.2 0.17 ± 0.05 10.4 ± 0.4 0.4 ± 0.06 23.5–18 1–1.5c
Humanb 0.7 ± 0.2 0.06 ± 0.03 7 0.13 ± 0.04 15 0.4–0.45c
Note. PDHn, Pyruvate dehydrogenase‐mediated pyruvate flux in neurons (equals flux in neuronal 
TCA cycle); PC, Pyruvate carboxylase‐mediated flux (astrocyte‐specific); %PC, Pyruvate carboxy‐
lase‐mediated flux as a percentage of total measured pyruvate metabolism; PDHg, Pyruvate dehy‐
drogenase‐mediated pyruvate flux in glial cells (astrocytes); %PDHg, Pyruvate 
dehydrogenase‐mediated pyruvate flux in astrocytes as a percent of the total measured pyruvate 
metabolism.
aHertz (2011). bHyder et al. (2006) Values for %PC and %PDH are calculated by the authors. 
cMcKenna et al. (2012). 
TA B L E  1   Metabolic fluxes (μmol/
min/g) in neurons and astrocytes 
measured in awake subjects using 13C 
MRS
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the importance of the PC‐catalyzed reaction in astrocytes without 
which citrate could not be released in considerable amounts. As 
mentioned above, this is due to the fact that citrate like α‐ketogluta‐
rate is a TCA cycle constituent and therefore its release would lead 
to the depletion of the TCA cycle constituent if no replenishment 
would be possible. The importance of this citrate release from astro‐
cytes in terms of brain function has been discussed by Westergaard, 
Banke, Wahl, Sonnewald, and Schousboe (1995), Westergaard et al. 
(2017) and a detailed outline of this is beyond this review.
2.8 | Balancing anaplerosis with cataplerosis
While the turnover rate of the TCA cycle is high reflecting the high 
energy consumption of the brain (McKenna et al., 2012), the concen‐
trations of the individual intermediaries are quite low and normally 
kept rather constant. It is therefore conceivable that the anaplerotic 
process allowing a net synthesis of its constituents must be coupled 
to release from the tissue and a cataplerotic process leading to the 
exit of intermediates from the TCA cycle including the conversion of 
4‐carbon units to 3‐carbon units. The role of anaplerotic reactions for 
cellular metabolism in the brain has been studied widely and is dis‐
cussed above. It is, however, less well known how this process is cou‐
pled to cataplerosis. Moreover, it is also not completely clear which 
roles that both of these pathways play in the regulation of amino acid, 
glucose, and fatty acid homeostasis. In the brain constituting a closed 
system due to the blood–brain barrier, a linkage between anaplerosis 
and cataplerosis should be emphasized. There may be several candi‐
date mechanisms for cataplerosis in the brain, one of which may be 
the loss of glutamine representing a possible way of counteracting 
anaplerosis. However, studies on glutamine release from brain have 
failed to show a substantial efflux (Dejong, Deutz, & Soeters, 1993).
Pyruvate recycling (Figure 2) represents a pathway for complete 
oxidation of glutamate and it is known to be active in the liver and 
has also been described in the brain by Cerdan, Kunnecke, and Seelig 
(1990). This recycling was originally believed to take place primarily 
in neurons and not in astrocytes because labeling patterns related to 
recycling were apparent in glutamate but not glutamine. Subsequent 
studies did, however, lead to the conclusion that this process is ac‐
tive in both astrocytes and neurons (Olsen & Sonnewald, 2015). 
The process of pyruvate recycling in the brain was additionally 
demonstrated in other animal studies (Haberg et al., 1998; Melo, 
Sonnewald, Touret, & Nehlig, 2006; Morken et al., 2014; Sonnewald, 
Therrien, & Butterworth, 1996). However, the process of pyruvate 
recycling could not be detected in rabbit brain or by in vivo MRS 
studies (Duarte, Lanz, & Gruetter, 2011; Lapidot & Gopher, 1994). 
The level of activity representing pyruvate recycling appears rather 
small and at present it does not appear conceivable that this pro‐
cess can match the activity of pyruvate carboxylation. Therefore, its 
physiological relevance has been debated and a logical explanation 
for the oxidation of glutamate to produce pyruvate would be an in‐
crease during hypoglycemia, a condition in which the pyruvate con‐
tent is low. Experiments designed to prove this have, however, so far 
failed to do so (Bakken, White, Unsgard, Aasly, & Sonnewald, 1998).
It may be of interest in this context that lactate may represent a 
metabolite that may be able to leave the brain in large enough quanti‐
ties to compensate for the constant anaplerosis by pyruvate carbox‐
ylation (Dienel, 2012). The hypothesis that a considerable fraction of 
cataplerosis in the brain may be brought about by exporting lactate 
generated from the intermediates of the TCA cycle into the blood 
stream and perivascular area was suggested by Sonnewald (2014). It 
was concluded that anaplerosis and cataplerosis must be tightly cou‐
pled and that glutamate might be the key compound connecting both, 
whereas lactate might serve as the “missing link.” This hypothesis also 
shifts the generally accepted paradigm that lactate is exclusively de‐
rived from glycolysis to a possibility that it may originate from oxida‐
tion and might explain the phenomenon of “aerobic glycolysis” (Goyal, 
Hawrylycz, Miller, Snyder, & Raichle, 2014) under resting conditions. 
Results which support this hypothesis (Sonnewald, 2014) are the find‐
ings that lactate can be produced from the TCA cycle as shown in 
a number of experiments both in vivo (Hassel & Sonnewald, 1995) 
and in cell cultures (Alves et al., 2000; Amaral, Teixeira, Sonnewald, 
& Alves, 2011) and as mentioned above, that lactate can be exported 
from the brain (Dienel, 2012). In this context, it may also be of im‐
portance to note the connection between glutamate concentration 
and lactate formation. It was shown that partial pyruvate recycling, 
i.e., lactate formation from the TCA cycle (Figure 2), did increase 
with increasing extracellular glutamate concentrations in astrocytes 
(McKenna, Sonnewald, Huang, Stevenson, & Zielke, 1996). Combining 
the results from several publications (Olsen & Sonnewald, 2015), this 
coupling between the external glutamate concentration and lactate 
formation was confirmed and lactate production from the TCA cycle 
was shown to be more active in astrocytes than neurons, in line with 
the astrocytes’ greater capacity for glutamate uptake.
Conducting conclusive experiments to clearly demonstrate cat‐
aplerotic pathways and how to couple them in a stoichiometric way 
to anaplerosis has been attempted but, thus far, without success. 
This is possibly due to the flexibility of the system and the many 
alternatives and, sometimes redundant, pathways that can be used.
2.9 | Ammonia homeostasis, glutamine 
synthetase, and alanine production: roles of PC and 
production of glycolytic pyruvate
Under physiological conditions, the ammonia concentration in the 
brain is maintained at very low levels due to the high activity of GS 
F I G U R E  2   Schematic presentation of partial (lactate formation) 
and full (re‐entry into the TCA cycle) pyruvate recycling. 
Abbreviation: TCA, tricarboxylic acid
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and its low Km value (0.2 mM) (Pamiljans, Krishnaswarmy, Dumville, 
& Meister, 1962). However, in a state of hepatic encephalopathy 
(HE) resulting from liver failure or disorders of urea cycle enzymes 
(Albrecht & Jones, 1999; Hazell & Butterworth, 1999), the ammonia 
concentration will rise drastically, a condition ultimately resulting 
in coma (Butterworth, 2002; Muñoz, 2008). During HE there is an 
increased synthesis of glutamine in an attempt to lower the am‐
monia level (Cooper, Mora, Cruz, & Gelbard, 1985; Hindfelt, Plum, 
& Duffy, 1977). This is associated with a stimulation of pyruvate 
carboxylation in order to compensate for an increased demand of 
α‐ketoglutarate to provide the carbon skeleton for increased glu‐
tamine synthesis (Kanamatsu & Tsukada, 1999; Lapidot & Gopher, 
1997; Zwingmann, Brand, Richter‐Landsberg, & Leibfritz, 1998). 
Interestingly, inhibition of GS with methionine sulfoximine (MSO) 
has been shown to increase alanine production, shifting the metab‐
olism of ammonia from fixation in glutamine to incorporation into 
alanine via the concerted action of glutamate dehydrogenase and 
alanine aminotransferase (Brusilow, Koehler, Traystman, & Cooper, 
2010; Dadsetan et al., 2011, 2013; Fries et al., 2014; Leke et al., 
2011). The latter series of processes lead to an enhanced glycolytic 
rate to provide pyruvate for alanine production (Dadsetan et al., 
2011, 2013; Leke et al., 2011), which may underline the flexibility of 
the regulation of activities of metabolic pathways.
3  | CONCLUSIONS
One important outcome of the discovery that pyruvate carboxyla‐
tion is an astrocytic, not neuronal process is the current concept that 
glutamatergic and GABAergic neurons are unable to perform a net 
synthesis of their neurotransmitters. In other words, there is an ob‐
ligatory need for transfer of the precursor of these transmitters, i.e., 
glutamine from astrocytes to neurons. While the above is now gener‐
ally accepted, it is still enigmatic to fully understand the mechanisms 
responsible for the balancing of anaplerosis, i.e., pyruvate carboxyla‐
tion, with cataplerosis. This appears to be an experimental challenge 
since several pathways may be involved in glutamate homeostasis.
Another intriguing finding related to pyruvate carboxylation 
is the capacity for astrocytes to produce and release significant 
amounts of citrate. It was originally thought that citrate might repre‐
sent a possible avenue for neurons to receive a TCA cycle constitu‐
ent from surrounding astrocytes, but this appears unlikely to be the 
case (Westergaard et al., 2017). Another function of citrate may be 
related to its ability to chelate zinc ions thereby modulating the ac‐
tivity of NMDA receptors as suggested by Westergaard et al. (1995). 
Again, conclusive evidence for the functional significance of this still 
remains to be obtained.
Altogether, while 35 years of research related to the functional 
role of astrocytic pyruvate carboxylase activity has provided import‐
ant new knowledge about the ability of astrocytes to influence in 
particular the glutamatergic activity, there may still be questions to 
be investigated such as how the balance between anaplerosis and 
cataplerosis is brought about.
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